TLDR: Regulated industries are purchasing brand-tech at scale and deploying it at a fraction of its potential because no existing education system trains executives at the compliance-marketing intersection — and purpose-built executive education is the structural fix the market has yet to supply at scale.
Compliance and Brand-Tech Demand the Same Person — Who Does Not Yet Exist
Executives in regulated industries occupy a peculiar professional position. Their organisations have invested substantially in AI-driven personalisation engines, omnichannel digital engagement tools, and data-rich customer experience platforms. Their marketing teams understand the tools exist. Their compliance and regulatory teams understand the rules that govern those tools’ use. The professional who holds both bodies of knowledge simultaneously — who can build an effective brand-tech campaign and navigate the compliance stack surrounding it in a pharmaceutical, financial, or energy context — remains rare in the extreme.
This is not a talent pipeline problem in the conventional sense. It is a structural curriculum gap. The programmes that produce senior marketing talent were not designed with the regulatory architecture of pharma or banking in mind. The compliance training that regulated organisations deliver to their staff was not designed to produce brand-tech capability. The consequence is predictable and persistent: brand-tech platforms are purchased at enterprise scale and deployed at a fraction of their designed potential, because the internal talent cannot bridge the gap between capability and constraint.
The Kainjoo Institute’s position is that this gap cannot be closed by internal workarounds or general AI literacy programmes alone. It requires purpose-built executive education at the compliance-marketing intersection — and the market for this category of training remains structurally underfilled.
The Data Makes the Structural Case
The scale of the gap is measurable across multiple industries and multiple primary sources.
In the pharmaceutical sector, GlobalData’s November 2024 survey of 109 pharmaceutical industry professionals found that “lack of specific skills and talents” was the single biggest obstacle to digital transformation, cited by 49% of respondents — a figure that had risen from 43% in 2023. The gap deepens as the technology advances, not the reverse.
In financial services, the Financial Services Skills Commission’s Future Skills Report 2025 documents demand running approximately 20% ahead of supply across the 13 critical skills the sector needs most, with AI-related skills carrying the largest individual supply-demand gap at 35 percentage points. The FSSC’s Annual Skills Report 2026 confirms the gap is not narrowing: firms report that skills shortages are raising operating costs, increasing workloads on existing staff, and directly impeding innovation and growth.
The World Economic Forum’s Future of Jobs Report 2025 situates these sector findings within a global pattern. Drawing on perspectives from more than 1,000 leading employers representing 14 million workers, the WEF identifies the skills gap as the primary barrier to business transformation, cited by 63% of employers — above capital constraints, regulatory uncertainty, and supply-chain disruption. Marketing and media skills rank among the roles expected to see significant demand growth through 2030, driven specifically by the need for digital experience delivery and data-informed customer understanding.
What connects all three data points is that the gap is widening, not closing, through conventional means.
What Large Regulated Companies Are Doing — and Why It Falls Short
Large regulated-industry organisations are not passive in the face of this gap. Their responses, however, reveal precisely why the structural problem persists.
AstraZeneca offers the most documented case. The company launched a tiered enterprise-wide AI training programme in 2024 — AI Foundations and GenAI Essentials — and by April 2026 had certified more than 17,000 employees across R&D, commercial, and marketing functions, with 96% of participants reporting direct applicability to their daily work. The programme represents substantial scale and internal investment.
Yet even AstraZeneca’s programme — one of the most ambitious workforce upskilling initiatives in the pharmaceutical sector — is designed around general AI literacy, not the specific capability that bridges brand-tech effectiveness with HCP engagement rules, promotional approval workflows, and pharmacovigilance disclosure requirements. General AI literacy is necessary; it is not sufficient for brand-tech deployment in a regulated context.
Sanofi’s approach addresses a different dimension of the same problem. The company developed an internal programme designed to force structured collaboration between data scientists and brand managers who would not naturally interact — in effect, building bridges across the knowledge gap that brand-tech deployment consistently creates. The initiative targets exactly the right problem. It is, by design, proprietary, internal, and non-transferable. It is an organisational workaround, not a scalable curriculum.
Both cases point to the same conclusion. Regulated companies are attempting to solve a curriculum gap with internal improvisation. The more cost-effective and scalable solution is a purpose-built external programme that delivers intersection expertise directly, rather than asking each organisation to re-derive it independently at considerable cost and with variable results.
Why Business Schools and Traditional Marketing Training Both Miss the Mark
The absence of an established market for regulated-industry brand-tech executive education reflects the incentive structures of traditional educational institutions, not a failure of demand.
Business school MBA programmes are designed to cover general management across industries. The specific compliance frameworks governing pharmaceutical promotional regulation — including the ABPI Code, FDA promotional rules, and EMA guidance — are absent from general management curricula. Their regulatory specificity also changes more frequently than standard accreditation cycles can accommodate. The same applies to financial marketing disclosure requirements under MiFID II and the FCA’s Consumer Duty framework, and to energy-sector communication standards aligned to mandatory ESG disclosure regimes.
Traditional marketing training organisations face the mirror problem. Accreditation frameworks such as those of the Chartered Institute of Marketing or the American Marketing Association produce competent general marketing practitioners. They do not produce practitioners who understand how to build an AI-personalisation workflow that satisfies a medical affairs review committee, or how to design a digital engagement campaign for retail banking customers within a regulated conduct framework.
The gap between these two bodies of training is precisely where regulated-industry executives operate every day — and precisely where no existing curriculum consistently goes.
Exhibit 1 — Kainjoo Institute Analysis
The Brand-Tech Capability Gap Across Regulated Industries
Source: Kainjoo Institute analysis; GlobalData 2024; Financial Services Skills Commission Future Skills Report 2025; WEF Future of Jobs Report 2025
| Industry | Core Brand-Tech Gap | Dominant Training Response | Why It Falls Short |
|---|---|---|---|
| Pharmaceuticals | AI personalisation within HCP engagement and promotional approval rules | General AI literacy programmes (e.g. enterprise-wide tiered certifications) | Does not address the compliance-marketing intersection; brand teams cannot deploy without recurring compliance escalation |
| Banking & Finance | Data-driven CX and personalisation within MiFID II, Consumer Duty, and FCA fair communications standards | Siloed compliance training OR generic digital marketing certification | Neither bridges regulatory constraint with brand-tech execution; AI skills gap at 35 percentage points (FSSC 2025) |
| Energy | Digital engagement and ESG-linked brand communication within mandatory disclosure frameworks | Technical and operations training; marketing treated as a support function | Commercial teams lack brand-tech capability; disclosure risk is managed defensively rather than as a strategic brand asset |
| Telecoms | Data personalisation and omnichannel CX within GDPR, ePrivacy, and sector-specific conduct codes | GDPR compliance training alongside standard CX and product marketing courses | Regulatory training focuses on risk avoidance; CX training ignores regulatory constraints; commercial teams operate in the gap between both |
The Structural Gap Demands a Structural Response
The global executive education programme market was valued at USD 10.1 billion in 2024 and is projected to reach USD 26.26 billion by 2033, growing at an 11.2% compound annual rate, with financial services accounting for the largest segment by industry type. This growth reflects a widespread recognition that formal degree programmes are too slow and too general to meet rapid, technology-driven capability needs. Organisations are increasing their investment in targeted executive programmes that deliver specific, applicable competence.
The structural opportunity for regulated-industry brand-tech education sits within this growth. Compressed-format programmes that deliver the compliance-marketing intersection — the model the Kainjoo Institute applies through its Nano-MBA approach — serve an audience that lacks both the time for a two-year MBA and the option of relying on internal improvisation. The regulated-industry executive who can personalise at scale within HCP rules, build a digital engagement programme within financial conduct standards, and measure brand-tech ROI within compliance-approved reporting frameworks is the most valuable professional these industries do not yet produce in volume.
The demand signal is consistent across every major workforce study. The supply-side response — purpose-built, regulated-industry-specific, compression-format executive education — is the structural gap. The market has identified what it needs. The question is which education providers build the curriculum at scale, and how fast they move to fill the space the evidence has already defined.
References
- GlobalData, “Lack of skills and talent still top hinderance for digital transformation in pharma,” November 2024: https://www.globaldata.com/media/pharma/lack-skills-talent-still-top-hinderance-digital-transformation-pharma-says-globaldata/
- Financial Services Skills Commission, Future Skills Report 2025: https://financialservicesskills.org/wp-content/uploads/2025/11/FSSC_Future_Skills_Report_2025.pdf
- Financial Services Skills Commission, Annual Skills Report 2026: https://financialservicesskills.org/wp-content/uploads/2026/03/Annual-Skills-Report-2026.pdf
- World Economic Forum, The Future of Jobs Report 2025: https://www.weforum.org/publications/the-future-of-jobs-report-2025/
- AstraZeneca, “Upskilling employees in the age of AI,” 2025: https://www.astrazeneca.com/media-centre/articles/2025/upskillingAI.html
- Fortune, “How AstraZeneca’s 17,000 AI-certified employees are helping it reach a ‘stretch goal’ of $80 billion in revenue,” April 2026: https://fortune.com/2026/04/30/astrazeneca-17000-ai-certified-employees-goal-80-billion-revenue-cfo/
- ScienceDirect, “Rewriting the textbook for pharma: how to adapt and thrive in a digital, personalized and collaborative world,” 2024: https://www.sciencedirect.com/science/article/pii/S135964462400237X
- PRNewswire, “Executive Education Program Market to Reach US$115.7 Bn by 2033,” 2025: https://www.prnewswire.com/news-releases/executive-education-program-market-to-reach-us115-7-bn-by-2033-expands-amid-corporate-upskilling-and-digital-learning-transformation-302757233.html
